Cardiofocus, Inc.
CardioFocus specializes in providing innovative tools for electrophysiologists to treat atrial fibrillation, focusing on science-driven, durable, and effective cardiac ablation solutions. Their portfolio includes the HeartLight X3 system and the Centauri pulsed field ablation platform, with a mission to optimize energy delivery and improve patient outcomes.
Industries
Nr. of Employees
medium (51-250)
Cardiofocus, Inc.
500 Nickerson Road, Marlborough, MA 01752
Patents
Endoscopically guided ablation catheters with thermally resistant balloons
US-12336757-B2
View Details
Endoscopically guided ablation catheters with thermally resistant balloons
US-12336757-B2
View DetailsProducts
Endoscopic balloon-based ablation system
Catheter-based system combining an ultra-compliant intraluminal balloon and endoscopic visualization for pulmonary vein isolation using continuous energy delivery and motorized positioning.
Focal pulsed field ablation generator platform
Open-platform pulsed field ablation generator designed to deliver configurable monopolar biphasic waveforms and to interface with focal contact-force catheters for intracardiac ablation workflows.
Next-generation pulsed field ablation clinical system
Clinical pulsed field ablation system intended for commercial and investigational use, supporting initial patient treatments and next-generation waveform and delivery features.
Endoscopic balloon-based ablation system
Catheter-based system combining an ultra-compliant intraluminal balloon and endoscopic visualization for pulmonary vein isolation using continuous energy delivery and motorized positioning.
Focal pulsed field ablation generator platform
Open-platform pulsed field ablation generator designed to deliver configurable monopolar biphasic waveforms and to interface with focal contact-force catheters for intracardiac ablation workflows.
Next-generation pulsed field ablation clinical system
Clinical pulsed field ablation system intended for commercial and investigational use, supporting initial patient treatments and next-generation waveform and delivery features.
Services
Provision of physician/operator training, instructional materials, and procedural videos to support safe device adoption and use.
Design and execution support for clinical studies, follow-up remapping studies, and publication collaboration with clinical investigators.
In-house design and execution of benchtop and animal-model experiments to evaluate energy delivery, lesion formation, and device safety.
Support for preparation of regulatory filings, labeling, and region-specific launch activities following approval.
Provision of physician/operator training, instructional materials, and procedural videos to support safe device adoption and use.
Design and execution support for clinical studies, follow-up remapping studies, and publication collaboration with clinical investigators.
In-house design and execution of benchtop and animal-model experiments to evaluate energy delivery, lesion formation, and device safety.
Support for preparation of regulatory filings, labeling, and region-specific launch activities following approval.
Expertise Areas
- Ablation therapy systems development
- Pulsed field ablation clinical translation
- Endoscopic visualization-guided cardiac ablation
- Preclinical benchtop and animal-model evaluation
Key Technologies
- Pulsed electric field (PEF) ablation
- Monopolar biphasic waveform generation
- Endoscopic visualization for cardiac procedures
- Balloon-based intraluminal ablation devices
News & Updates
CardioFocus Announces First Patients Treated with OptiShot™ Pulsed Field Ablation System
CardioFocus to Present Data Supporting Next Generation Pulsed Field Ablation Systems at Heart Rhythm 2024
CardioFocus Acquires Electrophysiology Division of Galvanize Therapeutics
CardioFocus Announces Pulsed Field Ablation Milestones
CardioFocus Announces Agreement to Acquire Intellectual Property
CardioFocus to Participate at the 6th Annual Needham Virtual Med Tech & Diagnostics 1×1 Conference
CardioFocus Announces First Patients Treated with OptiShot™ Pulsed Field Ablation System
CardioFocus to Present Data Supporting Next Generation Pulsed Field Ablation Systems at Heart Rhythm 2024
CardioFocus Acquires Electrophysiology Division of Galvanize Therapeutics
CardioFocus Announces Pulsed Field Ablation Milestones
CardioFocus Announces Agreement to Acquire Intellectual Property
CardioFocus to Participate at the 6th Annual Needham Virtual Med Tech & Diagnostics 1×1 Conference